Loading…

The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis

Summary Background The non‐invasive assessment of amyloid heart disease may be challenging. Cardiac magnetic resonance (CMR) represents a method of choice for assessment of left ventricular (LV) morphology and function, and it also provides a unique possibility to evaluate the presence of amyloid de...

Full description

Saved in:
Bibliographic Details
Published in:Clinical physiology and functional imaging 2016-05, Vol.36 (3), p.218-224
Main Authors: Fikrle, Michal, Palecek, Tomas, Masek, Martin, Kuchynka, Petr, Straub, Jan, Spicka, Ivan, Rysava, Romana, Linhart, Ales
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Background The non‐invasive assessment of amyloid heart disease may be challenging. Cardiac magnetic resonance (CMR) represents a method of choice for assessment of left ventricular (LV) morphology and function, and it also provides a unique possibility to evaluate the presence of amyloid deposition by the late gadolinium enhancement (LGE) technique. However, so far, published studies have not been consistent in terms of described LGE patterns associated with amyloid cardiomyopathy. Aims To compare echocardiographic and CMR assessment of LV morphology and function and to evaluate the presence and pattern of LGE in a population of patients with AL amyloid cardiomyopathy. Methods Twenty‐two consecutive patients with newly diagnosed AL amyloid cardiomyopathy and without contraindications to CMR were comprehensively examined by echocardiography and CMR. Results Echocardiography and CMR did not differ in the evaluation of interventricular septal thickness, LV end‐diastolic diameter and ejection fraction. Significant differences were found between echocardiographic and CMR estimates of LV end‐diastolic volume (P
ISSN:1475-0961
1475-097X
DOI:10.1111/cpf.12216